Physician profile
Christopher M Schroeder
NPI 1144669656
$3,616.41
in general payments reported to CMS, 2019-2025
24 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $37.82 · 2021: $536 · 2022: $357 · 2023: $583 · 2024: $581 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $903.79 | 2021-2025 | Augment Injectable, Prophecy, 7 X 23mm Citrelock Implant |
| Integra Lifesciences Corporation | $598.60 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Wright Medical Technology, INC. | $451.04 | 2019 | |
| Smith+Nephew, INC. | $257.48 | 2019-2025 | Renasys Touch, Grafix Pl |
| Kerecis Limited | $163.07 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Angiodynamics, INC. | $152.57 | 2021 | |
| Merck Sharp & Dohme LLC | $132.38 | 2019 | |
| Medartis INC. | $131.38 | 2019-2021 | |
| Bioventus LLC | $130.59 | 2019-2021 | |
| Melinta Therapeutics, LLC | $103.27 | 2019 | |
| Polynovo North America LLC | $96.37 | 2024-2025 | Novosorb Btm |
| Grt US Holding, INC. | $72.30 | 2021-2022 | |
| Axogen | $70.61 | 2019 | |
| Dynasplint Systems INC. | $60.02 | 2021 | |
| Innovation Technologies INC | $51.75 | 2025 | Irrisept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $48.88 | 2021 | |
| Kci USA, INC. | $37.85 | 2019-2023 | V.A.C. Veraflo Cleanse Choice |
| Djo, LLC | $29.58 | 2021 | |
| Depuy Synthes Sales INC. | $29.29 | 2019 | |
| Advanced Oxygen Therapy INC. | $25.75 | 2022 | |
| Tactile Systems Technology INC | $21.27 | 2025 | Nimbl, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $20.70 | 2021 | |
| Baudax Bio INC. | $14.17 | 2022 | |
| Treace Medical Concepts, INC. | $13.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.